Homologous recombination in HIV-1 and HTLV-1: a review with no FeLV-specific findings
Virus genes · 2026
In plain language
This review describes how HIV-1 and HTLV-1 interact with the systems that repair DNA in cells. It summarizes protein effects on DNA repair and on different steps in HIV-1 activity. Most strategies targeting one of these repair processes are supported primarily by preclinical research. The text contains no findings specific to cats or FeLV: it does not show that these mechanisms work the same way in that virus.
Scientific detail
The review, published in Virus genes in 2026, examines the role of homologous recombination in human retrovirus-associated diseases. The knowledge object classifies the species as multiple and does not report a sample size. The three mechanistic evidence statements presented here are rated evidence level D and come from prior research summarized in the review, not from feline-specific findings.
The review reports that HTLV-1 p30 suppresses homologous recombination and shifts double-strand break repair toward non-homologous end joining. It also reports that stimulation of RAD51 nucleofilament formation can restrict HIV-1 integration, while RAD51 can support HIV-1 LTR transcription. These are distinct effects on integration and transcription, respectively; they do not establish equivalent mechanisms in FeLV.
Whether elevated RAD51 in ATLL reflects an ineffective compensatory response to DNA damage or supports the survival of genetically unstable cells remains an open question. The authors also identify unresolved questions about direct interactions between RAD51 and viral proteins, and about HIV latency and reactivation. They state that most strategies targeting homologous recombination in retroviral infection are supported primarily by preclinical evidence. The supplied text has no dedicated limitations section.
The supplied text contains no feline or FeLV-specific findings. Its discussion of host DNA repair in HIV-1 and HTLV-1 provides only indirect mechanistic background for FeLV. Applying these mechanisms to FeLV would be an inference, not direct evidence.
What we know
The review summarizes level D evidence that HTLV-1 p30 suppresses homologous recombination and shifts double-strand break repair toward non-homologous end joining. It also reports that stimulation of RAD51 nucleofilament formation can restrict HIV-1 integration and that RAD51 can support HIV-1 LTR transcription. These statements concern distinct mechanisms summarized from prior research; they are not FeLV findings.
What we don't know
It remains unresolved whether elevated RAD51 in ATLL represents ineffective compensation for DNA damage or supports the survival of genetically unstable cells. Questions also remain about direct interactions between RAD51 and viral proteins, and about HIV latency and reactivation. The supplied text does not establish whether the described mechanisms occur in FeLV and provides no cat-specific evidence.
Evidence
EvidenceLevel D — Indirect evidence: other species or retrovirusConfidence 100/100
The review reports that HTLV-1 p30 suppresses homologous recombination and shifts double-strand break repair toward non-homologous end joining.
Excerpt verified in the source — verbatim, in the source's own language“Collectively, in HIV-1, RAD51 is upregulated and can support LTR transcription, whereas in HTLV-1, p30 suppresses HR and shifts double-strand break repair toward the non-homologous end-joining pathway.”
This describes an HTLV-1 protein-associated mechanism summarized from prior research. It does not demonstrate that FeLV proteins have the same effect.
EvidenceLevel D — Indirect evidence: other species or retrovirusConfidence 100/100
The review reports that stimulation of RAD51 nucleofilament formation can restrict HIV-1 integration.
Excerpt verified in the source — verbatim, in the source's own language“stimulation of RAD51 nucleofilament formation can restrict HIV-1 integration, highlighting its dual role as both a facilitator and a potential restriction factor.”
The statement concerns HIV-1 integration and is distinct from RAD51's reported transcriptional effects. It does not establish a corresponding restriction mechanism in FeLV.
EvidenceLevel D — Indirect evidence: other species or retrovirusConfidence 100/100
The review reports that RAD51 can support HIV-1 LTR transcription.
Excerpt verified in the source — verbatim, in the source's own language“Collectively, in HIV-1, RAD51 is upregulated and can support LTR transcription, whereas in HTLV-1, p30 suppresses HR and shifts double-strand break repair toward the non-homologous end-joining pathway.”
This is a review-level statement about HIV-1, not a feline finding. It does not establish that RAD51 supports FeLV transcription.
Open questionConfidence 100/100
Whether elevated RAD51 in ATLL reflects an ineffective compensatory response to DNA damage or supports survival of genetically unstable cells remains an open question.
The conclusion explicitly proposes these alternatives for future investigation rather than resolving them. Neither explanation is established for FeLV.
Provenance
Source: The role of homologous recombination in human retrovirus-associated diseases.
AVA